Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Descotes

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|July 7, 2017
Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urineFrançoise Descotes, Norelyakin Kara, Myriam Decaussin-Petrucci, et al.
Acta Oncologica (Stockholm, Sweden)|May 14, 2016
Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?Lucien Marchand, Cécile Nozières, Thomas Walter, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|December 12, 2018
Morphological features predictive for BRAF(V600E) mutation in papillary thyroid microcarcinomasAdela Corina Nechifor-Boilă, Emőke Andrea Szász, Françoise Descotes, et al.
The American Journal of Surgical Pathology|March 25, 2026
Insights From Mutational and Transcriptomic Profiles in Epithelial-myoepithelial CarcinomaZiyad Alsugair, Françoise Descotes, Anne Champagnac, et al.
Histopathology|May 6, 2024
Peculiar nuclear atypia associated with MDM2 gene amplification in carcinoma ex-pleomorphic adenoma harbouring an alteration of HMGA2Ziyad Alsugair, Maxime Fieux, Françoise Descotes, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 18, 2020
Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?Lucie Ravella, Jonathan Lopez, Françoise Descotes, et al.
Histopathology|September 29, 2023
Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovariiSophie Neyrand, Alexis Trecourt, Jonathan Lopez, et al.
Breast Cancer Research and Treatment|August 21, 2002
Prognostic assessment of PTK activity in T1-T2, N0-N1, M0 breast cancer: a multicentric retrospective studyBéatrice Rostaing-Puissant, Edmond M Chambaz, Sylvie Romain, et al.
Genes, Chromosomes & Cancer|May 15, 2024
Uncovering the WWTR1::NCOA2 Gene fusion in low-grade myoepithelial-rich neoplasm with HMGA2 expression: A case reportZiyad Alsugair, Daniel Pissaloux, Françoise Descotes, et al.
Cancer Research|July 8, 2011
Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerinAnaïs Fradet, Helène Sorel, Lamia Bouazza, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|July 7, 2017
Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urineFrançoise Descotes, Norelyakin Kara, Myriam Decaussin-Petrucci, et al.
Acta Oncologica (Stockholm, Sweden)|May 14, 2016
Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?Lucien Marchand, Cécile Nozières, Thomas Walter, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|December 12, 2018
Morphological features predictive for BRAF(V600E) mutation in papillary thyroid microcarcinomasAdela Corina Nechifor-Boilă, Emőke Andrea Szász, Françoise Descotes, et al.
The American Journal of Surgical Pathology|March 25, 2026
Insights From Mutational and Transcriptomic Profiles in Epithelial-myoepithelial CarcinomaZiyad Alsugair, Françoise Descotes, Anne Champagnac, et al.
Histopathology|May 6, 2024
Peculiar nuclear atypia associated with MDM2 gene amplification in carcinoma ex-pleomorphic adenoma harbouring an alteration of HMGA2Ziyad Alsugair, Maxime Fieux, Françoise Descotes, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 18, 2020
Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?Lucie Ravella, Jonathan Lopez, Françoise Descotes, et al.
Histopathology|September 29, 2023
Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovariiSophie Neyrand, Alexis Trecourt, Jonathan Lopez, et al.
Breast Cancer Research and Treatment|August 21, 2002
Prognostic assessment of PTK activity in T1-T2, N0-N1, M0 breast cancer: a multicentric retrospective studyBéatrice Rostaing-Puissant, Edmond M Chambaz, Sylvie Romain, et al.
Genes, Chromosomes & Cancer|May 15, 2024
Uncovering the WWTR1::NCOA2 Gene fusion in low-grade myoepithelial-rich neoplasm with HMGA2 expression: A case reportZiyad Alsugair, Daniel Pissaloux, Françoise Descotes, et al.
Cancer Research|July 8, 2011
Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerinAnaïs Fradet, Helène Sorel, Lamia Bouazza, et al.
Pageof 6